BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeuck TL, Wittekind C. Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases. Gastric Cancer. 2015;18:100-108. [PMID: 24550066 DOI: 10.1007/s10120-014-0352-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Feng HY, Zhang Y, Liu HJ, Dong X, Yang SC, Lu Q, Meng F, Chen HZ, Sun P, Fang C. Characterization of an orthotopic gastric cancer mouse model with lymph node and organ metastases using bioluminescence imaging. Oncol Lett 2018;16:5179-85. [PMID: 30250585 DOI: 10.3892/ol.2018.9313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zeng YJ, Zhang CD, Dai DQ. Impact of lymph node micrometastasis on gastric carcinoma prognosis: A meta-analysis. World J Gastroenterol 2015; 21(5): 1628-1635 [PMID: 25663783 DOI: 10.3748/wjg.v21.i5.1628] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
3 You X, Wang Y, Wu J, Liu Q, Chen D, Tang D, Wang D. Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients With Gastric Carcinoma. Technol Cancer Res Treat 2019;18:1533033819832856. [PMID: 30827194 DOI: 10.1177/1533033819832856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Blouhos K, Boulas KA, Hatzigeorgiadis A. Clinical significance of lymph nodes micrometastasis in conventionally node-negative advanced gastric cancer. Updates Surg 2017;69:425-6. [PMID: 28210961 DOI: 10.1007/s13304-017-0420-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Liu JY, Deng JY, Zhang NN, Liu HF, Sun WL, He WT, Wang Y, Zhang L, Liang H. Clinical significance of skip lymph-node metastasis in pN1 gastric-cancer patients after curative surgery. Gastroenterol Rep (Oxf) 2019;7:193-8. [PMID: 31217983 DOI: 10.1093/gastro/goz008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Pereira MA, Ramos MFKP, Dias AR, Yagi OK, Faraj SF, Zilberstein B, Cecconello I, Mello ES, Ribeiro U Jr. DETECTION OF OCCULT LYMPH NODE TUMOR CELLS IN NODE-NEGATIVE GASTRIC CANCER PATIENTS. Arq Bras Cir Dig 2017;30:30-4. [PMID: 28489165 DOI: 10.1590/0102-6720201700010009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
7 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016; 8(2): 136-146 [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 De Marco C, Biondi A, Ricci R. N staging: the role of the pathologist. Transl Gastroenterol Hepatol 2017;2:10. [PMID: 28275742 DOI: 10.21037/tgh.2017.01.02] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhou Y, Zhang GJ, Wang J, Zheng KY, Fu W. Current status of lymph node micrometastasis in gastric cancer. Oncotarget 2017;8:51963-9. [PMID: 28881703 DOI: 10.18632/oncotarget.17495] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
10 Deng J, Yamashita H, Seto Y, Liang H. Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients. Ann Surg Oncol. 2017;24:745-753. [PMID: 27770340 DOI: 10.1245/s10434-016-5513-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
11 Blouhos K, Boulas KA, Tsalis K, Barettas N, Aftzoglou M, Hatzigeorgiadis A. Recurrence of a pT2N0cM0 Lower Third Gastric Cancer with No. 6 Lymph Node Micrometastasis after R0 Extended Surgery. Should Adjuvant Therapy be Performed in Conventionally Node-Negative but Micrometastasis-Positive pT2 Gastric Cancer? J Gastrointest Cancer 2017;48:89-93. [PMID: 26907363 DOI: 10.1007/s12029-016-9811-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Chen SB, Liu DT, Huang SJ, Weng HR, Wang G, Li H, Chen YP. Prognostic value of occult lymph node metastases in patients with completely resected esophageal squamous cell carcinoma. Sci Rep 2020;10:22007. [PMID: 33319855 DOI: 10.1038/s41598-020-79073-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lin JX, Wang ZK, Huang YQ, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Zheng CH, Huang CM, Li P. Clinical Relevance of Splenic Hilar Lymph Node Dissection for Proximal Gastric Cancer: A Propensity Score-Matching Case-Control Study. Ann Surg Oncol 2021. [PMID: 33768400 DOI: 10.1245/s10434-021-09830-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Chen YJ, Yeh ST, Ou LH, Lin CS, Chien CT. Impact of the extent of negative lymph nodes in gastric adenocarcinoma undergoing primary surgical resection: An institutional report. J Chin Med Assoc 2021;84:428-37. [PMID: 33595989 DOI: 10.1097/JCMA.0000000000000500] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 He H, Shen Z, Wang X, Qin J, Sun Y, Qin X. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy. Jpn J Clin Oncol 2015;46:63-70. [DOI: 10.1093/jjco/hyv159] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
16 Tavares A, Wen X, Maciel J, Carneiro F, Dinis-Ribeiro M. Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered? Ann Surg Oncol 2020;27:4204-15. [PMID: 32367500 DOI: 10.1245/s10434-020-08524-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Giampieri R, Del Prete M, Cantini L, Baleani MG, Bittoni A, Maccaroni E, Berardi R. Optimal management of resected gastric cancer. Cancer Manag Res 2018;10:1605-18. [PMID: 29950898 DOI: 10.2147/CMAR.S151552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]